Boehringer Ingelheim to Pay $95 Million to Resolve False Claims Act Allegations--- Government Alleges Company Improperly Marketed Three Drugs
/ Published Oct. 25, 2012
Boehringer Ingelheim to Pay $95 Million to Resolve False Claims Act Allegations--- Government Alleges Company Improperly Marketed Three Drugs